ReviewArchives of toxicology2026
Genotoxicity of anthraquinone dyes and dye intermediates: a comprehensive review.
Review in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anthraquinone dyes and dye intermediates are widely used across industrial, pharmaceutical, and biological applications. Despite evidence that both synthetic and naturally occurring anthraquinones may exhibit genotoxic effects, a complete assessment of their genotoxic potential is currently lacking. This review provides a comprehensive evaluation of genotoxicity data for anthraquinone dyes and dye intermediates derived from bacterial assays, mammalian in vitro systems, and in vivo models. Data from studies assessing gene mutation, chromosomal damage, DNA damage, and DNA repair were integrated. Genotoxic activity was common but substance-specific and frequently confined to particular endpoints or strains rather than consistent across the test battery. Of the 63 anthraquinones evaluated, ten including 1-amino-2-methyl-anthraquinone, 2-aminoanthraquinone, aloe emodin, chrysazin, emodin, Disperse Blue 3, Disperse Blue 7, Disperse Red 11, rubiadin and Acid Blue 62 showed consistent evidence of genotoxic activity, whereas carminic acid can be considered non-genotoxic on the available evidence. For many compounds the evidence remained insufficient to draw definitive conclusions, highlighting the need for further studies conducted in accordance with Organisation for Economic Co-operation and Development guidelines.
Indexed as
Identifiers
42742702What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.